List of Tables
Table 1. Global Coronary Drug-Eluting Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Coronary Drug-Eluting Stent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Coronary Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2024
Table 4. Global Coronary Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Coronary Drug-Eluting Stent Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Coronary Drug-Eluting Stent Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Coronary Drug-Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Coronary Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Coronary Drug-Eluting Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Coronary Drug-Eluting Stent, Product Type & Application
Table 12. Global Key Manufacturers of Coronary Drug-Eluting Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coronary Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Drug-Eluting Stent as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Coronary Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 18. Global Coronary Drug-Eluting Stent Sales Market Share by Region (2020-2025)
Table 19. Global Coronary Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)
Table 20. Global Coronary Drug-Eluting Stent Sales Market Share by Region (2026-2031)
Table 21. Global Coronary Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Coronary Drug-Eluting Stent Revenue Market Share by Region (2020-2025)
Table 23. Global Coronary Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Coronary Drug-Eluting Stent Revenue Market Share by Region (2026-2031)
Table 25. North America Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 27. North America Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
Table 28. North America Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 32. Europe Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
Table 33. Europe Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Coronary Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Coronary Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Coronary Drug-Eluting Stent Sales (K Units) by Type (2020-2025)
Table 51. Global Coronary Drug-Eluting Stent Sales (K Units) by Type (2026-2031)
Table 52. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2020-2025)
Table 53. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2026-2031)
Table 54. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2020-2025)
Table 57. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2026-2031)
Table 58. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2020-2025)
Table 59. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2026-2031)
Table 60. Global Coronary Drug-Eluting Stent Sales (K Units) by Application (2020-2025)
Table 61. Global Coronary Drug-Eluting Stent Sales (K Units) by Application (2026-2031)
Table 62. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2020-2025)
Table 63. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2026-2031)
Table 64. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2020-2025)
Table 67. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2026-2031)
Table 68. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2020-2025)
Table 69. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Coronary Drug-Eluting Stent Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Coronary Drug-Eluting Stent Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Coronary Drug-Eluting Stent Product
Table 84. Abbott Recent Developments/Updates
Table 85. B.Braun Company Information
Table 86. B.Braun Description and Business Overview
Table 87. B.Braun Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. B.Braun Coronary Drug-Eluting Stent Product
Table 89. B.Braun Recent Developments/Updates
Table 90. Biosensors International Company Information
Table 91. Biosensors International Description and Business Overview
Table 92. Biosensors International Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Biosensors International Coronary Drug-Eluting Stent Product
Table 94. Biosensors International Recent Developments/Updates
Table 95. MicroPort Company Information
Table 96. MicroPort Description and Business Overview
Table 97. MicroPort Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. MicroPort Coronary Drug-Eluting Stent Product
Table 99. MicroPort Recent Developments/Updates
Table 100. Lepu Medical Company Information
Table 101. Lepu Medical Description and Business Overview
Table 102. Lepu Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Lepu Medical Coronary Drug-Eluting Stent Product
Table 104. Lepu Medical Recent Developments/Updates
Table 105. Terumo Company Information
Table 106. Terumo Description and Business Overview
Table 107. Terumo Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Terumo Coronary Drug-Eluting Stent Product
Table 109. Terumo Recent Developments/Updates
Table 110. Blue Sail Medical Company Information
Table 111. Blue Sail Medical Description and Business Overview
Table 112. Blue Sail Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Blue Sail Medical Coronary Drug-Eluting Stent Product
Table 114. Blue Sail Medical Recent Developments/Updates
Table 115. SINOMED Company Information
Table 116. SINOMED Description and Business Overview
Table 117. SINOMED Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. SINOMED Coronary Drug-Eluting Stent Product
Table 119. SINOMED Recent Developments/Updates
Table 120. Liaoning Yinyi Biological Company Information
Table 121. Liaoning Yinyi Biological Description and Business Overview
Table 122. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product
Table 124. Liaoning Yinyi Biological Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Coronary Drug-Eluting Stent Distributors List
Table 128. Coronary Drug-Eluting Stent Customers List
Table 129. Coronary Drug-Eluting Stent Market Trends
Table 130. Coronary Drug-Eluting Stent Market Drivers
Table 131. Coronary Drug-Eluting Stent Market Challenges
Table 132. Coronary Drug-Eluting Stent Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Coronary Drug-Eluting Stent
Figure 2. Global Coronary Drug-Eluting Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Coronary Drug-Eluting Stent Market Share by Type: 2024 & 2031
Figure 4. Polymer Stent Product Picture
Figure 5. Polymer-Free Stent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Coronary Drug-Eluting Stent Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Coronary Drug-Eluting Stent Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Coronary Drug-Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Coronary Drug-Eluting Stent Market Size (2020-2031) & (US$ Million)
Figure 13. Global Coronary Drug-Eluting Stent Sales (2020-2031) & (K Units)
Figure 14. Global Coronary Drug-Eluting Stent Average Price (US$/Unit) & (2020-2031)
Figure 15. Coronary Drug-Eluting Stent Report Years Considered
Figure 16. Coronary Drug-Eluting Stent Sales Share by Manufacturers in 2024
Figure 17. Global Coronary Drug-Eluting Stent Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Coronary Drug-Eluting Stent Players: Market Share by Revenue in Coronary Drug-Eluting Stent in 2024
Figure 19. Coronary Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
Figure 22. North America Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
Figure 23. United States Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
Figure 26. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
Figure 27. Germany Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Coronary Drug-Eluting Stent Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Coronary Drug-Eluting Stent Revenue Market Share by Region (2020-2031)
Figure 34. China Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
Figure 42. Latin America Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Coronary Drug-Eluting Stent by Type (2020-2031)
Figure 52. Global Revenue Market Share of Coronary Drug-Eluting Stent by Type (2020-2031)
Figure 53. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Coronary Drug-Eluting Stent by Application (2020-2031)
Figure 55. Global Revenue Market Share of Coronary Drug-Eluting Stent by Application (2020-2031)
Figure 56. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2020-2031)
Figure 57. Coronary Drug-Eluting Stent Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
